10
Sep 2026
Experts call for gradual independence before children reach adolescence
As thousands of children start secondary school, experts have called for children to be given more opportunities for independence before they hit adolescence.
Stay Informed!
10
Sep 2026
New treatment approach preserves organs, improves survival in head and neck cancer patients
Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors responded to neoadjuvant immunochemotherapy (ICT) and who underwent less extensive surgery had high disease-free survival and organ preservation rates.
10
Sep 2026
New funding supports LMU research on pediatric inflammatory bowel disease
The non-profit Boehringer Ingelheim Stiftung supports LMU clinician-scientist Daniel Kotlarz through its Rise up! program.
10
Sep 2026
New AI tool predicts breast cancer risk using repeated 3D mammograms
An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more effective at predicting five-year risk of developing breast cancer than a tool that uses only the most recent, single 3D mammogram, as well as an AI model that analyzes 2D mammograms, a new study shows.
10
Sep 2026
Symptomless liver condition linked to heart and kidney disease
A common liver condition thought to be harmless could be dramatically increasing the risk of heart disease, kidney failure and premature death, according to a new review led by University of Manchester and Northern Care Alliance NHS Foundation Trust researchers.
10
Sep 2026
Compassion and connection at heart of suicide prevention
Compassion, trust and person-centerd care must be at the heart of supporting people experiencing suicidal distress, according to a leading Adelaide University suicide prevention expert.
10
Sep 2026
Evaluating new approaches for rare disease research
Marcel Nelen discusses his team’s early evaluation of a new workflow for rare disease genomics.
10
Sep 2026
Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at Peking Union Medical College Hospital, while Shanghai Pulmonary Hospital has also enrolled its first patient on the same day.
10
Sep 2026
Nighttime light exposure may alter heart structure and function
Exposure to light during the nighttime is linked to important and potentially harmful changes to the structure and function of the heart, according to a study of more than 11,000 people published in the European Heart Journal today (Thursday).
10
Sep 2026
Tizanidine looked promising early in a migraine trial, but the benefit did not last
A randomized, double-blind, placebo-controlled trial found that low-dose tizanidine did not provide sustained reductions in headache burden over 12 weeks in people with episodic migraine, despite a transient improvement with the 1 mg dose at week 4. Exploratory analyses suggested that smoking and sex may influence tizanidine exposure, while sex-specific efficacy signals remained hypothesis-generating and require confirmation.
